Not only did SLE sera support up-regulation of IDO in a type I IFN-dependent manner, but also SLE patients with ongoing type I IFN activity in vivo had increased IDO activity as well as decreased serotonin levels. Here, IDO1 is linked to systemic lupus erythematosus.